467 related articles for article (PubMed ID: 28634109)
1. Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
[TBL] [Abstract][Full Text] [Related]
2. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
[TBL] [Abstract][Full Text] [Related]
3. Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study.
Delvecchio G; Oldani L; Mandolini GM; Pigoni A; Ciappolino V; Schiena G; Lazzaretti M; Caletti E; Barbieri V; Cinnante C; Triulzi F; Brambilla P
J Vis Exp; 2020 Aug; (162):. PubMed ID: 32894263
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids, reward processing, and psychosis.
Gunasekera B; Diederen K; Bhattacharyya S
Psychopharmacology (Berl); 2022 May; 239(5):1157-1177. PubMed ID: 33644820
[TBL] [Abstract][Full Text] [Related]
5. Human Laboratory Studies on Cannabinoids and Psychosis.
Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
[TBL] [Abstract][Full Text] [Related]
6. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
7. Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research.
Schoedel KA; Harrison SJ
Curr Pharm Des; 2012; 18(32):5008-14. PubMed ID: 22716155
[TBL] [Abstract][Full Text] [Related]
8. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Krebs MO; Kebir O; Jay TM
Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
[TBL] [Abstract][Full Text] [Related]
9. Cannabis and psychosis: an update on course and biological plausible mechanisms.
Linszen D; van Amelsvoort T
Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
[TBL] [Abstract][Full Text] [Related]
10. Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
Curran HV; Hindocha C; Morgan CJA; Shaban N; Das RK; Freeman TP
Psychol Med; 2019 Jul; 49(9):1574-1580. PubMed ID: 30176957
[TBL] [Abstract][Full Text] [Related]
11. Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed.
Mandelbaum DE; de la Monte SM
Pediatr Neurol; 2017 Jan; 66():12-20. PubMed ID: 27789118
[TBL] [Abstract][Full Text] [Related]
12. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
Morgan CJ; Curran HV
Br J Psychiatry; 2008 Apr; 192(4):306-7. PubMed ID: 18378995
[TBL] [Abstract][Full Text] [Related]
13. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
14. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
[TBL] [Abstract][Full Text] [Related]
15. Cannabis Use and the Risk for Psychosis and Affective Disorders.
Sideli L; Quigley H; La Cascia C; Murray RM
J Dual Diagn; 2020; 16(1):22-42. PubMed ID: 31647377
[No Abstract] [Full Text] [Related]
16. Cannabis, cannabinoids, and health.
Lafaye G; Karila L; Blecha L; Benyamina A
Dialogues Clin Neurosci; 2017 Sep; 19(3):309-316. PubMed ID: 29302228
[TBL] [Abstract][Full Text] [Related]
17. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Weinstein A; Livny A; Weizman A
Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids and psychosis.
D'Souza DC
Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
[TBL] [Abstract][Full Text] [Related]
19. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
Arnold JC; Boucher AA; Karl T
Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133
[TBL] [Abstract][Full Text] [Related]
20. What is the mechanism whereby cannabis use increases risk of psychosis?
Luzi S; Morrison PD; Powell J; di Forti M; Murray RM
Neurotox Res; 2008 Oct; 14(2-3):105-12. PubMed ID: 19073418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
